Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 6:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 80 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: In Vitro diagnostic tests Clear all

Conditions: Multiple Myeloma in Relapse
Interventions: Not listed
Lead sponsor: Travera Inc; Industry
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 4
States / cities: Duarte, California • Boston, Massachusetts • New York, New York

Conditions: Infection
Interventions: STD Diagnostic Kit (Identigene); Device
Lead sponsor: Identigene; Industry
Eligibility: 14 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Preeclampsia
Interventions: Not listed
Lead sponsor: Carl Weiner, MD; Other
Eligibility: 16 Years to 45 Years · Female only
Enrollment: 431 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Intra-Amniotic Infection of Foetus
Interventions: Perilynx Analyzer to measure AF and VF fluid; Diagnostic Test
Lead sponsor: Hologic, Inc.; Industry
Eligibility: 18 Years to 50 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 5
States / cities: Long Beach, California • Shreveport, Louisiana • Newark, New Jersey + 2 more

Conditions: Lung Cancer, Technology, Oncology
Interventions: Idylla EGFR Mutation Test; Diagnostic Test
Lead sponsor: Anthony Magliocco; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Urinary Tract Infections
Interventions: Velieve U.S.; Device
Lead sponsor: Healthy.io Ltd.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: West Palm Beach, Florida

Conditions: Cancer
Interventions: protein expression analysis, immunohistochemistry staining method, laboratory biomarker analysis, biopsy; Genetic · Other · Procedure
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: Up to 120 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Breast Neoplasms, Breast Diseases
Interventions: Not listed
Lead sponsor: Sysmex America, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Tucson, Arizona • Houston, Texas

Conditions: Streptococcus Pyogenes Infection, Pharyngitis, Respiratory Tract Infections
Interventions: untrained lay user performs investigational diagnostic test; Diagnostic Test
Lead sponsor: Checkable Medical Inc; Industry
Eligibility: 5 Years and older
Enrollment: 1,347 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 22
States / cities: Beverly Hills, California • Jacksonville, Florida • Miami, Florida + 18 more

Conditions: Coronavirus, Respiratory Infection, COVID
Interventions: Investigational IVD for coronaviruses; Device
Lead sponsor: BioFire Defense LLC; Industry
Eligibility: Not listed
Enrollment: 2,091 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 6
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Tampa, Florida + 3 more

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Fiberoptic bronchoscopy, blood draw, intravenous catheter; Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Single Gene Disorders
Interventions: Preimplantation Genetic Diagnosis; Other
Lead sponsor: Natera, Inc.; Industry
Eligibility: Not listed
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Human T-Lymphotrophic Virus Type I and/or Type II
Interventions: InnoLIA HTLV I/II Score line immunoassay; Device
Lead sponsor: Creative Testing Solutions; Other
Eligibility: Not listed
Enrollment: 3,305 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Kidney Failure, Acute, Kidney Failure, Chronic, Blood Platelet Disorders, Hemorrhage
Interventions: measuring Platelet Function Analyser-100 (PFA-100) platelet function before kidney biopsy; Device
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Influenza
Interventions: fluID Rapid Influenza Test, BinaxNOW® Influenza A & B; Device
Lead sponsor: Nanogen, Inc.; Industry
Eligibility: Not listed
Enrollment: 650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 2
States / cities: Shreveport, Louisiana • Milwaukee, Wisconsin

Conditions: Urine Detectable Acute and Chronic Diseases
Interventions: Dip Home-Based Dipstick Analyzer, Urine analysis predicate device for professional user; Diagnostic Test · Device
Lead sponsor: Healthy.io Ltd.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 429 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 3
States / cities: Atlanta, Georgia • Methuen, Massachusetts • Garden City, New York

Conditions: Urine Detectable Acute and Chronic Diseases
Interventions: Experimental: Dip Home-Based Dipstick Analyzer; Device
Lead sponsor: Healthy.io Ltd.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 3
States / cities: Atlanta, Georgia • Methuen, Massachusetts • Garden City, New York

Conditions: Influenza
Interventions: fluID Rapid Influenza Test; Device
Lead sponsor: Nanogen, Inc.; Industry
Eligibility: Not listed
Enrollment: 1,300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 12
States / cities: San Diego, California • DeLand, Florida • Shreveport, Louisiana + 8 more

Conditions: B-Cell Lymphoproliferative Disorder
Interventions: IdentiClone Dx IGH (IC IGH Dx) Assay; Diagnostic Test
Lead sponsor: Invivoscribe, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: San Diego, California

Conditions: Liver Diseases, Healthy, Liver Cirrhosis, Liver Fibrosis
Interventions: Adult; Diagnostic Test
Lead sponsor: Group K Diagnostics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Preimplantation Gentic Screening (PGS), In Vitro Fertilization (IVF), Preimplantation Genetic Diagnosis (PGD)
Interventions: 24 Chromosome Aneuploidy Screening with Parental Support; Device
Lead sponsor: Natera, Inc.; Industry
Eligibility: 35 Years to 42 Years · Female only
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 9
States / cities: Laguna Hills, California • Washington D.C., District of Columbia • Clearwater, Florida + 6 more

Conditions: Pneumonia, Methicillin-Resistant Staphylococcus Aureus
Interventions: Polymerase Chain Reaction (PCR); Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sexually Transmitted Diseases
Interventions: Visby Medical Men's STI PCR Test Kit; Diagnostic Test
Lead sponsor: Visby Medical; Industry
Eligibility: 14 Years and older · Male only
Enrollment: 507 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 5
States / cities: Fort Lauderdale, Florida • Miami Lakes, Florida • Atlanta, Georgia + 2 more

Conditions: Androgenetic Alopecia
Interventions: 5% minoxidil topical foam; Drug
Lead sponsor: Applied Biology, Inc.; Industry
Eligibility: 18 Years to 49 Years · Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Tucson, Arizona • Nashville, Tennessee

Search by objective public record fields.

Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma

Identigene STD Test Collection Kit Validation Study

A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk

Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test

Idylla EGFR Lung Trial

A Comparative, Controlled Study to Evaluate the Clinical Accuracy of the Velieve U.S. UTI Urine Analysis Test System

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy

Clinical Performance of the Checkable Medical At-Home Strep A Test

Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses

Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM)

Clinical Use of Parental Support To Detect Single Gene Mutations

Evaluation of InnoLIA HTLV I/II Score

Does An Abnormal PFA 100 Predict Bleeding After Renal Biopsy?

Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B

A Comparative, Controlled Study to Evaluate the Lay User Accuracy and Performance of the Dip Home-Based Dipstick Analyzer

Dip Home-Based Dipstick Analyzer Performance Evaluation

Prospective Evaluation of the Fluid Rapid Influenza Test

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx IGH Assay

Blood Collection for Development and Validation of Point-of-Care Diagnostic Liver Function Tests

Impact of Parental Support on Pregnancy Outcomes (IPSO) Trial- Day 3 Preimplantation Genetic Screening (PGS) With Day 5 Fresh Transfer

Trial of MRSA Polymerase Chain Reaction for Pneumonia

Clinical Evaluation of Visby Medical Men's Sexual Health Test

Minoxidil Response Testing in Males With Androgenetic Alopecia